Cannabinoids for gastrointestinal diseases: potential therapeutic applications.
about
Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammationThe endocannabinoid system as an emerging target of pharmacotherapyCannabinoids and intestinal motility: welcome to CB2 receptorsBotanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A ReviewUlcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissueRole of Cannabinoids in Gastrointestinal Mucosal Defense and InflammationThe cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease.The role of peripheral cannabinoid receptors type 1 in rats with visceral hypersensitivity induced by chronic restraint stress.Lipidomic metabolism analysis of the endogenous cannabinoid anandamide (N-arachidonylethanolamide)Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown.Involvement of cannabinoid receptors in gut motility and visceral perception.Cannabis and endocannabinoid modulators: Therapeutic promises and challenges.Endocannabinoids and the gastrointestinal tract: what are the key questions?Metabolism of Anandamide by Human Cytochrome P450 2J2 in the Reconstituted System and Human Intestinal Microsomes.Mechanisms for recycling and biosynthesis of endogenous cannabinoids anandamide and 2-arachidonylglycerol.The endogenous cannabinoid system protects against colonic inflammation.Rectal colonization by group B Streptococcus as a predictor of vaginal colonization.Rimonabant, gastrointestinal motility and obesity.Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes.Cannabinoid 1 (CB1) receptors coupled to cholinergic motorneurones inhibit neurogenic circular muscle contractility in the human colon.The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2.Cannabinoid receptor agonist WIN-55,212-2 protects differentiated PC12 cells from organophosphorus- induced apoptosis.Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon.Distribution and function of the cannabinoid-1 receptor in the modulation of ion transport in the guinea pig ileum: relationship to capsaicin-sensitive nerves.Do Cannabinoids Confer Neuroprotection Against Epilepsy? An Overview.Inactivation of Anandamide Signaling: A Continuing Debate.Endocannabinoids and Food Intake: Newborn Suckling and Appetite Regulation in AdulthoodIntestinal Monoacylglycerol Metabolism
P2860
Q24643922-48C3032D-93BF-46B7-A7E9-00B504537579Q24648473-5A38B272-8236-492F-B18E-594E2261053DQ24671720-54C34918-1F97-4D0B-8142-7E7F97EEC5B9Q26998841-EB094DA6-9439-43B4-9FCF-6B820AF0A819Q27342536-D25402D7-4DA9-488D-A922-8AED635BA2B8Q30357558-0F25BBE3-397F-4B58-A095-67B6795B4E23Q33535863-723CB7C6-66DD-4CDA-9D0C-C695C852117BQ34028431-62FA14C4-DB31-41D3-BE72-0032207371EAQ34282147-70A22654-2F47-42C5-A731-7A92E62899C4Q34818110-3C972DAE-3142-4BB0-AE1C-6D192955BC27Q35752224-6A6EF826-AF36-4C56-BA77-A9328004C2E9Q36892931-598501EB-AA93-46E3-9585-9A32BC565530Q36927486-126BE451-6B92-41E8-BADC-6F013C42FF13Q36947747-0E41FFDA-8CE2-46CA-B08B-1695CF4FEA5DQ36968568-8DCD6381-BB19-4457-B7BE-26906B090C60Q37370275-3E442E00-B5E9-4A38-B930-5785E34F2426Q37406543-98664F0B-295D-4B32-918B-C72A465E5EDFQ38085530-4BD919F9-A1B7-497B-A7F8-11E446AE027FQ38598509-8849D5A4-7C7F-488D-B88B-E9AF971D7DB0Q38758022-1C4F72D7-0EB7-483B-9E13-D0B8BA70E5D8Q40385552-8A93D541-9E1C-4D7B-98B8-9E45737C50D1Q43119640-E0B7446B-6448-4C2A-9691-676EAE2EBB75Q44534174-D033B59F-6101-4DD1-8923-9511E75702BEQ44710513-49959B66-DC93-47D6-B2DD-37E81DCE655FQ47125735-1A155439-315D-444C-9E09-59703CA191A9Q55506553-EE30C866-4CCA-4A75-BE1F-70C3D21CE97AQ55881660-A49DC01E-D1C3-4A99-AEE5-D0454FF6CCC3Q57843934-41023142-7C89-4406-8ED5-508F4F63EA71
P2860
Cannabinoids for gastrointestinal diseases: potential therapeutic applications.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cannabinoids for gastrointestinal diseases: potential therapeutic applications.
@ast
Cannabinoids for gastrointestinal diseases: potential therapeutic applications.
@en
Cannabinoids for gastrointestinal diseases: potential therapeutic applications.
@nl
type
label
Cannabinoids for gastrointestinal diseases: potential therapeutic applications.
@ast
Cannabinoids for gastrointestinal diseases: potential therapeutic applications.
@en
Cannabinoids for gastrointestinal diseases: potential therapeutic applications.
@nl
prefLabel
Cannabinoids for gastrointestinal diseases: potential therapeutic applications.
@ast
Cannabinoids for gastrointestinal diseases: potential therapeutic applications.
@en
Cannabinoids for gastrointestinal diseases: potential therapeutic applications.
@nl
P356
P1476
Cannabinoids for gastrointestinal diseases: potential therapeutic applications.
@en
P2093
Angelo A Izzo
Giulia Di Carlo
P356
10.1517/13543784.12.1.39
P407
P577
2003-01-01T00:00:00Z